Cardiovascular Medicine
Showing 11-20 of 28 Results
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD, PhD physician-scientist aiming to advance precision medicine for cardiovascular disease through research in genomics and artificial intelligence.
MD, The University of Tokyo, Tokyo, 2013
Residency in Internal Medicine, National Center for Global Health and Medicine, Tokyo, 2013-2017
Residency in Cardiology, Sakakibara Heart Institute, Tokyo, 2015–2017
PhD, The University of Tokyo, Tokyo, 2021
Clinical Fellow in Cardiology, The University of Tokyo Hospital, Tokyo, 2021–2022
Postdoctoral Scholar, Stanford University, 2023–present
Research interest: Precision medicine in cardiovascular disease. Genomics, Artificial Intelligence -
Samuel Montalvo
Postdoctoral Scholar, Cardiovascular Medicine
BioAs a clinical exercise physiologist, sport scientist, and biomechanist, I study the mechanical, physiological, and molecular determinants of human performance and health. I am certified as a Performance and Sport Scientist (CPSS), Strength and Conditioning Specialist with Distinction (CSCS,*D), and Clinical Exercise Physiologist.
I am a Postdoctoral Scholar in Cardiovascular Medicine at Stanford University and a member of the Stanford Bioinformatics Core and Wu Tsai Human Performance Alliance. My training has been supported by the Wu Tsai Human Performance Alliance Postdoctoral Fellowship, the NIH T32 Research Training in Myocardial Biology at Stanford, and a two-year NIH/NHLBI Loan Repayment Program award in Research in Emerging Areas Critical to Human Health.
My research integrates clinical exercise physiology, cardiopulmonary exercise testing, biomechanics, and multi-omics to better understand how physical activity influences cardiovascular health, biological adaptation, and athletic performance. Through the NIH-funded Molecular Transducers of Physical Activity Consortium, I analyze large clinical, multi-omic, multi-tissue, multi-modality, and multi-species datasets to identify mechanisms and biomarkers of exercise response.
I also collaborate on projects involving sports cardiology and electrocardiography, cardiopulmonary exercise testing, exercise and neuromuscular disease, and athlete performance, including work with Stanford Baseball and external sports-science collaborators.
Teaching and mentoring are central to my academic work. As a first-generation college graduate and Mexican American with Indigenous heritage, I am committed to creating supportive and inclusive pathways for trainees from underrepresented backgrounds. I serve as a Postdoctoral Mentoring Coach with the Stanford Office of Postdoctoral Affairs, participate in the Stanford PRISM program, and mentor prospective and current medical students through the MAVERICs program within the Stanford Cardiovascular Institute.
My long-term goal is to lead an independent research program that combines exercise physiology, multi-omics, physical activity, nutrition, cardiovascular science, and sports performance while mentoring the next generation of scientists. -
Andrew Thai Nguyen
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Scholar, Cardiovascular MedicineBioDr. Andrew Nguyen is a Cardiologist and a Clinical Scholar in the Department of Medicine, Division of Cardiovascular Medicine. He earned his medical degree from Harvard Medical School in the Harvard-MIT Health Sciences and Technology Program. He then completed his residency in Internal Medicine at Stanford University, followed by fellowship training in Cardiovascular Medicine also at Stanford University.
As a non-invasive cardiologist, Dr. Nguyen cares for patients undergoing cancer therapy as well as cancer survivors in the Stanford Health Care Cardio-Oncology Program. He provides evidenced-based cardiovascular care for patients throughout their cancer journey while managing and preventing treatment toxicities. Dr. Nguyen is a physician scientist who is mentored by Dr. Paul Cheng and Dr. Tom Quertermous. His research blends his clinical interest in cardio-oncology with basic science to understand the complex interplay between cancer angiogenesis and ischemic heart disease. He is a recipient of the AHA Postdoctoral Fellowship Award, ACC/Merck Research Fellowship Award, and NIH F32 Award.
